This review highlights how nanoparticle technology enhances drug delivery in malignant tumors, suggesting solutions for scalability and toxicity issues.
Key Points
Nanoparticle technology improves drug delivery in malignant tumors, increasing treatment effectiveness.
Investigating viral nanoparticles and virus-like particles reveals their potential for enhanced targeted therapies.
Challenges like production scalability and chronic toxicity must be addressed for effective application.
Incorporating magnetic hyperthermia demonstrates a novel approach to selectively destroying cancer cells.